InteGen Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 4


  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $4.18M

InteGen General Information


Developer of an interphase chromosome profiling tool designed for the cytogenetics community. The company's platform offers multiple-sequential hybridizations and a two-dual filter detection system to achieve comprehensive genome coverage, enabling fertility clinics and IVF doctors with clinical and cost-effective tools to detect balanced and unbalanced sub-telomere rearrangements.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Primary Office
  • 8865 Commodity Circle
  • Suite 2
  • Orlando, FL 32819
  • United States
+1 (407) 000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

InteGen Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Seed Round 23-Oct-2018 $4.18M 00.000 Completed Startup
1. Angel (individual) 24-Jan-2011 00000 00000 Completed Startup
To view InteGen’s complete valuation and funding history, request access »

InteGen Executive Team (1)

Name Title Board Seat Contact Info
Ramesh Vallabhaneni Founder & Chief Executive Officer
To view InteGen’s complete executive team members history, request access »

InteGen Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial